Cyclezyme appoints Stefan Lundström CEO of melanin unit MelaNova Bioscience

Reuters2026/09/09 16:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cyclezyme appointed Stefan Lundström CEO of newly formed subsidiary MelaNova Bioscience, created to develop and commercialize its biomimetic melanin patent.
Lundström brings experience in CEO leadership, international business development, sales, brand building, capital raising, and market expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclezyme AB published the original content used to generate this news brief via Cision (Ref. ID: 202609091200BITN____UKPR__SV_20260909-BIT-8193-0) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cyclezyme appoints Stefan Lundström CEO of melanin unit MelaNova Bioscience

You may also like

Crypto prices